ArticleBMC pediatrics2025
Development and validation of bleeding prediction model for percutaneous liver biopsy in children.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the current status and factors influencing the occurrence of percutaneous liver biopsy bleeding in children through a retrospective study, and to develop and validate a risk prediction model to reduce the incidence of percutaneous liver biopsy bleeding in children.
methodsFrom the hospital's electronic medical record system, clinical data of the study subjects were obtained during their hospitalization. Continuous variables were described using the median (interquartile range), while categorical variables were described using frequencies, proportions, and rates. Feature variables were screened using Lasso regression, and the data were divided into training and validation sets in a 7:3 ratio. Variables with statistically significant differences were included in a binary logistic regression model, and a risk prediction model was constructed using stepwise bidirectional regression. The model was visualized using a nomogram and internally validated. The ROC curve was used to assess the model's discriminative ability, the calibration curve to evaluate its calibration, and the decision curve analysis to assess its clinical decision-making capability.
resultsThe incidence of bleeding in this study was 13.3%, most of which were minor and did not cause serious complications. Variables with meaningful Lasso regression coefficients were included in the multivariate logistic regression analysis, and the stepwise bidirectional regression ultimately yielded seven independent influencing factors: Pre-Corticosteroid, Post Liver Transplantation, Needle Depth, ALT, PT, PLT, and GPR. These factors will be used to construct a prediction model for percutaneous liver biopsy bleeding in children. In this study, the training set AUC was 0.720, with a 95% CI of 0.675-0.765, and the validation set AUC was 0.700, with a 95% CI of 0.633-0.767.
conclusionThis study created and internally tested a bleeding prediction model for children undergoing percutaneous liver biopsy, demonstrating moderate discriminative ability. Additional optimization and external validation are necessary. Expanding research with larger, multi-center datasets is crucial to enhancing the model's predictive accuracy and clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.